Terns Pharmaceuticals Inc (STU:430)
€ 5.6 0.05 (0.9%) Market Cap: 470.26 Mil Enterprise Value: 113.82 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 39/100

Terns Pharmaceuticals Inc Obesity Franchise Webinar Transcript

Jun 29, 2023 / 03:00PM GMT
Release Date Price: €7.89 (+16.54%)
Justin Ng;Erin Quirk
Terns Pharmaceuticals, Inc. - IR;Terns Pharmaceuticals, Inc. - President &

Good morning, ladies and gentlemen, and welcome to the Terns Pharmaceuticals conference call. My name is Justin Ng, Director of Corporate Development and Investor Relations. As a reminder, this conference call is being recorded and a webcast of this call will be archived on the Terns website. At this time, all participants are in listen-only mode.

Following our presentation, we will open the line for a question-and-answer session. I would like to remind you that during this call, we will be making forward-looking statements that are subject to risks and uncertainties. Our actual results may differ materially from those described. We encourage you to review our risk factors in our most recent quarterly report on Form 10-Q, which can be found on our website. While we may elect to update these forward-looking statements in the future, we specifically disclaim any obligation to do so.

Now I'll turn the call over to Erin Quirk, President and Head of R&D.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot